Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss
But what should you do
The first thing you would notice is how much energy it gives you and helps with focusing
PlexusDx recommends genetic testing to confirm whether tirzepatide's dual-receptor mechanism aligns with your peptide-pathway strengths
Mechanistic themes seen in preclinical research In animal and mechanistic work, AOD-9604 has been associated with: Increased lipolysis (breaking down stored fat) Reduced lipogenesis (reducing fat storage) Interactions with -adrenergic pathways in adipose tissue have been discussed as part of its lipolytic signaling profile (OUP Academic) In obese animal models, AOD-9604 has shown reductions in body weight and body fat and changes consistent with increased fat mobilization
Acknowledgments: During the preparation of this manuscript/study, the author(s) used OpenAI GPT-4 and Perplexity AI GPT-4 for the purposes of extracting relevant quotations from full text articles, analyzing risk of bias for studies, generating a summary table, and generating a graphical abstract
